4D Molecular Therapeutics Maps Phase 3 4D-150 Timeline, DME Expansion in Barclays Conference Talk [Yahoo! Finance]
4D Molecular Therapeutics, Inc. (FDMT)
Company Research
Source: Yahoo! Finance
progress, and commercialization plans during a Barclays analyst discussion in Miami, highlighting its lead retinal program 4D-150 and an earlier-stage effort in cystic fibrosis. Company overview and platform Chief Financial Officer August Moretti described 4D Molecular Therapeutics as a “next-generation gene therapy company” founded about 12 years ago. He said the company's platform is based on directed evolution to develop vectors and capsids that are more tissue-specific, which management believes can enable safer dosing and expand gene therapy into larger market indications. ? Broadcom's AI Momentum Could Be Far From Over Moretti said the company's lead program, 4D-150, is advancing in Phase 3 for retinal disease, with lead indications in wet age-related macular degeneration (wet AMD) and plans to start a Phase 3 study in diabetic macular edema (DME) later this year. The company also has a cystic fibrosis program. How 4D-150 is positioned in wet AMD Chief Commercial and
Show less
Read more
Impact Snapshot
Event Time:
FDMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FDMT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FDMT alerts
High impacting 4D Molecular Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
FDMT
News
- 4DMT to Participate in Upcoming Investor MeetingsGlobeNewswire
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at TD Cowen 46th Annual Health Care Conference Prepared Remarks Transcript [Seeking Alpha]Seeking Alpha
- Where is 4D Molecular Therapeutics (FDMT) Headed According to the Street? [Yahoo! Finance]Yahoo! Finance
- 4DMT to Participate in Upcoming Investor ConferencesGlobeNewswire
FDMT
Earnings
- 11/10/25 - Beat
FDMT
Sec Filings
- 2/17/26 - Form SCHEDULE
- 2/17/26 - Form SCHEDULE
- 2/17/26 - Form SCHEDULE
- FDMT's page on the SEC website